In trading on Tuesday, the State Street SPDR S&P Biotech ETF is outperforming other ETFs, up about 3.5% on the day. Components of that ETF showing particular strength include shares of Myriad Genetics, up about 37.5% and shares of Sagimet Biosciences, up about 12.4% on the
Mostramos publicamente o ponto principal. Crie uma conta gratuita para continuar lendo o artigo completo, salva-lo, comenta-lo e conecta-lo ao contexto de mercado e OSINT.